Jeil Pharmaceutical Co., Ltd.
48
2
2
33
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.1%
1 terminated/withdrawn out of 48 trials
97.1%
+10.6% vs industry average
21%
10 trials in Phase 3/4
3%
1 of 33 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (48)
Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention
Role: collaborator
JAQBO® Tab. 20 mg(Zastaprazan Citrate) in Erosive GERD
Role: lead
Observationa Study is a Prospective and Multi-institutional Observational Study.
Role: lead
To Evaluate the Safety, Pharmacokinetic Characteristics and the Effect of Food After Administration of JLP-2004
Role: lead
To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901
Role: lead
To Evaluate the Safety and Pharmacokinetic Characteristics After Multiple Administration of JC-013 and JLP-2004
Role: lead
To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008
Role: lead
Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients
Role: lead
The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)
Role: collaborator
A Study of Lubiprostone to Treat Constipation
Role: lead
A Study of NOV140201 (JPI-547) in Subject With Advanced Solid Tumors
Role: collaborator
To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Role: lead
To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
Role: lead
To Evaluate the Efficacy and Safety of JLP-2002 on Symptoms of Overactive Bladder
Role: lead
Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects
Role: lead
The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers
Role: lead
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
Role: collaborator
Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
Role: lead
Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Role: lead
The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers
Role: lead